Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Gene Therapy
Papillary thyroid carcinoma after recombinant GH therapy for Turner syndrome
December 15th, 2005
Recent research from Spain has reported on papillary thyroid carcinoma after recombinant growth hormone (GH) therapy for Turner syndrome (TS). "TS has been included for several years among the indications for GH treatment, generally with satisfactory outcomes. Nevertheless, the long-term effects of this treatment in non-GH deficient patients are not fully known," wrote P. Cabanas and colleagues, University of Santiago de Compostela. "The incidence of thyroid carcinoma is rare in patients during childhood; it is unusual to find this neoplasia in children under sixteen years old. This article reports the cases of two Spanish patients with papillary...
Source: Women's Health Weekly (2005-12-15)
|
